CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash and Restricted Cash
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Cash and Restricted Cash of $240.58 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $240.58M.
- 2026-03-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $198.20M.
- 2025-12-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $216.00M.
- 2025-09-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $209.22M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-27 | $240.58M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $198.20M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $216.00M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $209.22M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $184.74M 10-Q · filed 2026-08-05 |
| 2025-03-29 | $231.73M 10-Q · filed 2026-05-07 |
| 2024-12-28 | $205.57M 10-Q · filed 2026-08-05 |
| 2024-09-28 | $211.64M 10-Q · filed 2025-11-05 |
| 2024-06-29 | $181.00M 10-Q · filed 2025-08-06 |
| 2024-03-30 | $338.54M 10-Q · filed 2025-05-07 |
| 2023-12-30 | $284.48M 10-K · filed 2026-02-18 |
| 2023-09-30 | $165.62M 10-Q · filed 2024-11-06 |
| 2023-07-01 | $208.78M 10-Q · filed 2024-08-07 |
| 2023-04-01 | $208.89M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $241.21M 10-K · filed 2026-02-18 |
| 2022-09-24 | $196.18M 10-Q · filed 2023-11-08 |
| 2022-06-25 | $207.21M 10-Q · filed 2023-08-09 |
| 2022-03-26 | $243.40M 10-Q · filed 2023-05-11 |
| 2021-12-25 | $246.31M 10-K · filed 2025-02-19 |
| 2021-09-25 | $226.50M 10-Q · filed 2022-11-02 |
| 2021-06-26 | $227.49M 10-Q · filed 2022-08-03 |
| 2021-03-27 | $471.02M 10-Q · filed 2022-05-04 |
| 2020-12-26 | $233.12M 10-K · filed 2024-02-14 |
| 2020-09-26 | $247.42M 10-Q · filed 2021-11-03 |
| 2020-06-27 | $404.04M 10-Q · filed 2021-08-04 |
| 2020-03-28 | $374.45M 10-Q · filed 2021-05-04 |
| 2019-12-28 | $240.05M 10-K · filed 2023-02-22 |
| 2019-09-28 | $166.72M 10-Q · filed 2020-10-29 |
| 2019-06-29 | $202.59M 10-Q · filed 2020-08-05 |
| 2019-03-30 | $128.31M 10-Q · filed 2020-05-07 |
| 2018-12-29 | $197.32M 10-K · filed 2022-02-16 |
| 2018-09-29 | $141.88M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $195.37M 10-Q · filed 2019-07-31 |
| 2018-03-31 | $190.40M 10-Q · filed 2019-05-07 |
| 2017-12-30 | $166.33M 10-K · filed 2021-02-17 |
| 2017-09-30 | $126.15M 10-Q · filed 2018-11-07 |
| 2017-07-01 | $119.02M 10-Q · filed 2018-08-08 |
| 2017-04-01 | $133.83M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $119.89M 10-K · filed 2020-02-11 |
| 2016-09-24 | $108.12M 10-Q · filed 2017-11-09 |
| 2016-06-25 | $156.91M 10-Q · filed 2017-08-09 |
| 2015-12-26 | $119.96M 10-K · filed 2019-02-13 |
| 2014-12-27 | $162.57M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |